Completed PHASE4 INTERVENTIONAL 2-arm NCT00419471

Escitalopram in Depressive Patients With Acute Coronary Artery Syndrome

Efficacy and Safety of Escitalopram in the Treatment of Depressive Patients With Acute Coronary Artery Syndrome: A Double-blind Placebo-controlled Trial

Sponsor: Chonnam National University Hospital

Conditions Coronary Disease Depressive Disorder

Interventions Escitalopram Placebo

Updated 6 times since 2017 Last updated: Jun 11, 2013 Started: May 31, 2007 Primary completion: Mar 31, 2013 Completion: Mar 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00419471, this PHASE4 trial focuses on Coronary Disease and Depressive Disorder and remains completed. Sponsored by Chonnam National University Hospital, it has been updated 6 times since 2007, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

May 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chonnam National University Hospital
H. Lundbeck A/S

Data source: Chonnam National University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Gwangju, South Korea